ETF Managers Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

ETF Managers Group’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$1.35M	Sell	2,818 -822	-23%	-$385K	0.04%	169
2022 Q4	$1.53M	Buy	3,640 +390	+12%	+$157K	0.07%	122
2022 Q3	$1.36M	Sell	3,250 -671	-17%	-$335K	0.04%	179
2022 Q2	$1.95M	Buy	3,921 +673	+21%	+$351K	0.06%	165
2022 Q1	$1.89M	Sell	3,248 -1,022	-24%	-$616K	0.04%	210
2021 Q4	$3.24M	Buy	4,270 +861	+25%	+$644K	0.06%	187
2021 Q3	$2.55M	Sell	3,409 -2,167	-39%	-$1.62M	0.05%	181
2021 Q2	$3.6M	Sell	5,576 -224	-4%	-$136K	0.06%	167
2021 Q1	$3.27M	Sell	5,800 -300	-5%	-$178K	0.06%	157
2020 Q4	$3.51M	Buy	6,100 +304	+5%	+$173K	0.08%	141
2020 Q3	$2.99M	Buy	5,796 +3,471	+149%	+$1.76M	0.09%	135
2020 Q2	$1M	Buy	+2,325	New	+$1.03M	0.04%	177

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ETF Managers Group's BIO Position: Q1 2023 in Review

ETF Managers Group reduced its Bio-Rad Laboratories Class A (BIO) stake by 23% in Q1 2023, selling an estimated $385K and leaving 2,818 shares worth $1.35M. The position accounts for 0.04% of the portfolio, ranked #169.

ETF Managers Group first reported a position in BIO in Q2 2020 and has held it in 12 quarters since. The position peaked at $3.6M in Q2 2021. 504 funds tracked by Wall St. Rank hold BIO as of Q1 2023.

ETF Managers Group held 2,818 shares of Bio-Rad Laboratories Class A worth $1.35M as of Q1 2023.
ETF Managers Group sold 822 Bio-Rad Laboratories Class A shares in Q1 2023, an estimated $385K.
Bio-Rad Laboratories Class A made up 0.04% of ETF Managers Group's portfolio in Q1 2023, its #169 holding.
ETF Managers Group first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and has held it in 12 quarters since.
ETF Managers Group's Bio-Rad Laboratories Class A position peaked at $3.6M in Q2 2021.
504 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.